Log in to your Inderes Free account to see all free content on this page.
Xbrane Biopharma
0.156
SEK
-4.29 %
XBRANE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
8 following
-4.29%
-27.27%
0%
-44.19%
-86.24%
-83.6%
-98.6%
-96.03%
-95.91%
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Read moreMarket cap
239.02M SEK
Turnover
936.64K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
21.2.
2025
Annual report '24
5.5.
2025
General meeting '24
8.5.
2025
Interim report Q1'25
ShowingAll content types
XBRANE BIOPHARMA'S PRINCIPAL OWNER SYSTEMATIC GROUP PROVIDES A SHORT-TERM LOAN OF SEK 20 M TO THE COMPANY
Xbrane AB (publ) today announces that the company's CFO, Anette Lindqvist, has announced her intention to retire and will leave her position during the spring of 2025.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio